USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER

The present invention relates to an in vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing cancer, said method comprising the step of determining, in a sample from said patient which is suspected to comprise neoplastic or cancerous tissue,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ITALIANO, ANTOINE, LE LOARER, FRANCOIS
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ITALIANO, ANTOINE
LE LOARER, FRANCOIS
description The present invention relates to an in vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing cancer, said method comprising the step of determining, in a sample from said patient which is suspected to comprise neoplastic or cancerous tissue, whether or not the sample comprises a tertiary lymphoid structure (TLS), and prognosing disease progression, wherein the prognosis is an assessment regarding the likelihood of improved survival of the patient, and/or better clinical outcome of an immunotherapy. La présente invention concerne une méthode in vitro destinée au pronostic de progression de la maladie chez un patient souffrant d'un cancer ou susceptible d'en développer un, ladite méthode comprenant l'étape consistant à déterminer, dans un échantillon provenant dudit patient chez qui un tissu néoplasique ou cancéreux est suspecté, si l'échantillon comprend ou non une structure lymphoïde tertiaire (TLS) et à pronostiquer la progression de la maladie, le pronostic étant une évaluation concernant la probabilité de survie améliorée du patient et/ou un meilleur résultat clinique d'une immunothérapie.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3183131A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3183131A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3183131A13</originalsourceid><addsrcrecordid>eNqNy7EKwjAQxvEsDqK-w72AQ8jiGtKLCdik3F2GTqWUdBIt1PdHiz6A0wd_ft9eTYURsgdBkmiph1vfdiHHBlioOCmEDD4TSEDoKF9T5sjbo4mMlr_xgzjmBJsjtNJiEogJnE0O6ah283hf6-m3BwUexYVzXZ5DXZdxqo_6Gpw1-mK00VabP8gb7Po0Cg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER</title><source>esp@cenet</source><creator>ITALIANO, ANTOINE ; LE LOARER, FRANCOIS</creator><creatorcontrib>ITALIANO, ANTOINE ; LE LOARER, FRANCOIS</creatorcontrib><description>The present invention relates to an in vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing cancer, said method comprising the step of determining, in a sample from said patient which is suspected to comprise neoplastic or cancerous tissue, whether or not the sample comprises a tertiary lymphoid structure (TLS), and prognosing disease progression, wherein the prognosis is an assessment regarding the likelihood of improved survival of the patient, and/or better clinical outcome of an immunotherapy. La présente invention concerne une méthode in vitro destinée au pronostic de progression de la maladie chez un patient souffrant d'un cancer ou susceptible d'en développer un, ladite méthode comprenant l'étape consistant à déterminer, dans un échantillon provenant dudit patient chez qui un tissu néoplasique ou cancéreux est suspecté, si l'échantillon comprend ou non une structure lymphoïde tertiaire (TLS) et à pronostiquer la progression de la maladie, le pronostic étant une évaluation concernant la probabilité de survie améliorée du patient et/ou un meilleur résultat clinique d'une immunothérapie.</description><language>eng ; fre</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220120&amp;DB=EPODOC&amp;CC=CA&amp;NR=3183131A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220120&amp;DB=EPODOC&amp;CC=CA&amp;NR=3183131A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ITALIANO, ANTOINE</creatorcontrib><creatorcontrib>LE LOARER, FRANCOIS</creatorcontrib><title>USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER</title><description>The present invention relates to an in vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing cancer, said method comprising the step of determining, in a sample from said patient which is suspected to comprise neoplastic or cancerous tissue, whether or not the sample comprises a tertiary lymphoid structure (TLS), and prognosing disease progression, wherein the prognosis is an assessment regarding the likelihood of improved survival of the patient, and/or better clinical outcome of an immunotherapy. La présente invention concerne une méthode in vitro destinée au pronostic de progression de la maladie chez un patient souffrant d'un cancer ou susceptible d'en développer un, ladite méthode comprenant l'étape consistant à déterminer, dans un échantillon provenant dudit patient chez qui un tissu néoplasique ou cancéreux est suspecté, si l'échantillon comprend ou non une structure lymphoïde tertiaire (TLS) et à pronostiquer la progression de la maladie, le pronostic étant une évaluation concernant la probabilité de survie améliorée du patient et/ou un meilleur résultat clinique d'une immunothérapie.</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAQxvEsDqK-w72AQ8jiGtKLCdik3F2GTqWUdBIt1PdHiz6A0wd_ft9eTYURsgdBkmiph1vfdiHHBlioOCmEDD4TSEDoKF9T5sjbo4mMlr_xgzjmBJsjtNJiEogJnE0O6ah283hf6-m3BwUexYVzXZ5DXZdxqo_6Gpw1-mK00VabP8gb7Po0Cg</recordid><startdate>20220120</startdate><enddate>20220120</enddate><creator>ITALIANO, ANTOINE</creator><creator>LE LOARER, FRANCOIS</creator><scope>EVB</scope></search><sort><creationdate>20220120</creationdate><title>USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER</title><author>ITALIANO, ANTOINE ; LE LOARER, FRANCOIS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3183131A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>ITALIANO, ANTOINE</creatorcontrib><creatorcontrib>LE LOARER, FRANCOIS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ITALIANO, ANTOINE</au><au>LE LOARER, FRANCOIS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER</title><date>2022-01-20</date><risdate>2022</risdate><abstract>The present invention relates to an in vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing cancer, said method comprising the step of determining, in a sample from said patient which is suspected to comprise neoplastic or cancerous tissue, whether or not the sample comprises a tertiary lymphoid structure (TLS), and prognosing disease progression, wherein the prognosis is an assessment regarding the likelihood of improved survival of the patient, and/or better clinical outcome of an immunotherapy. La présente invention concerne une méthode in vitro destinée au pronostic de progression de la maladie chez un patient souffrant d'un cancer ou susceptible d'en développer un, ladite méthode comprenant l'étape consistant à déterminer, dans un échantillon provenant dudit patient chez qui un tissu néoplasique ou cancéreux est suspecté, si l'échantillon comprend ou non une structure lymphoïde tertiaire (TLS) et à pronostiquer la progression de la maladie, le pronostic étant une évaluation concernant la probabilité de survie améliorée du patient et/ou un meilleur résultat clinique d'une immunothérapie.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3183131A1
source esp@cenet
subjects CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
title USE OF TERTIARY LYMPHOID STRUCTURES FOR THE PROGNOSIS OF DISEASE PROGRESSION OR TREATMENT IN CANCER
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T21%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ITALIANO,%20ANTOINE&rft.date=2022-01-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3183131A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true